Research programme: dendrimer-based proteins and monoclonal antibodies - StarpharmaAlternative Names: ADME Engineering; Dendrimer-antibodies; Dendrimer-monoclonal antibody formulations - Starpharma; Dendrimer-protein formulations - Starpharma; Dendrimer-proteins
Latest Information Update: 08 May 2012
At a glance
- Originator Starpharma
- Class Dendrimers; Monoclonal antibodies; Proteins
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Unspecified